Reset Pharma is a privately-held biotechnology company focused on the development and commercialization of novel psychedelic treatments for patients with life-threatening illnesses, including cancer. The company’s lead program focuses on psilocybin with psychotherapy for patients with cancer related demoralization, anxiety and depression. Reset Pharma has established a highly experienced biotech development team and has a Scientific Advisory Board of leading experts in psychiatry, oncology and psychedelics.
Company Details
- Employees
- 3
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.resetpharma.com/
Reset Pharmaceuticals Questions
Reset Pharmaceuticals's website is https://www.resetpharma.com/
Reset Pharmaceuticals's LinkedIn profile is https://www.linkedin.com/company/resetpharma
Reset Pharmaceuticals has
3 employees.
View email and phone details for 3
employees at Reset Pharmaceuticals.
Reset Pharmaceuticals's industry is
Biotechnology Research
Reset Pharmaceuticals's top competitors are
Seelos Therapeutics, Inc.,
Mindmed,
Psymed Ventures,
Freedom Biosciences,
Adheretech,
Delix Therapeutics,
Wiselayer | Makers Of Accruals.ai,
Compass Pathways,
Gilgamesh Pharmaceuticals,
Transcend Therapeutics.
Reset Pharmaceuticals's categories are Biotechnology Research
